Labels:text | screenshot | black and white | black | font | document OCR: tuitar There is little doubt that patients with ‹ of tumours run a small, but significant, ris icy. It is lute risk. expansion of the tumour during pregna very difficult, however, to assess the abs ns to be With microadenomas, the incidence see han 0.5 per less than one per cent and probably less Te cent. In patients with macroadenomas, ween five incidence is probably higher, perhaps be ed to and twenty per cent. This risk is unrelate y but may bromocriptine therapy prior to pregnan r drugs, occur when fertility is induced with oth including exogenous gonadotrophins al erapy has clomiphene, and even when no drug th ing been employed in patients with pre-exis pituitary adenomas. lot great In practice, the problem of pregnancy is resent with since the vast majority of women who enomas. hyper ...
(.png)
